HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,542,820 | -6.1% | 145,100 | -11.3% | 0.01% | +12.5% |
| Q2 2023 | $5,900,367 | -12.1% | 163,581 | -6.9% | 0.01% | -20.0% |
| Q1 2023 | $6,713,420 | -34.6% | 175,790 | -2.6% | 0.01% | -37.5% |
| Q4 2022 | $10,267,662 | +44.2% | 180,451 | +0.2% | 0.02% | +33.3% |
| Q3 2022 | $7,119,000 | -11.0% | 180,054 | -1.0% | 0.01% | -7.7% |
| Q2 2022 | $8,000,000 | +11.3% | 181,827 | +0.8% | 0.01% | +44.4% |
| Q1 2022 | $7,191,000 | -8.7% | 180,309 | -8.0% | 0.01% | 0.0% |
| Q4 2021 | $7,880,000 | +0.5% | 195,973 | +1.6% | 0.01% | -10.0% |
| Q3 2021 | $7,843,000 | -11.1% | 192,803 | -0.8% | 0.01% | -9.1% |
| Q2 2021 | $8,822,000 | +5.5% | 194,267 | -3.1% | 0.01% | 0.0% |
| Q1 2021 | $8,362,000 | -2.8% | 200,581 | -0.4% | 0.01% | -8.3% |
| Q4 2020 | $8,600,000 | +59.2% | 201,360 | -2.0% | 0.01% | +33.3% |
| Q3 2020 | $5,402,000 | -1.4% | 205,542 | +0.6% | 0.01% | -10.0% |
| Q2 2020 | $5,480,000 | +49.0% | 204,396 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $3,677,000 | -5.2% | 204,396 | -6.5% | 0.01% | +14.3% |
| Q4 2019 | $3,877,000 | +12.1% | 218,645 | -2.0% | 0.01% | 0.0% |
| Q3 2019 | $3,460,000 | -8.6% | 223,062 | +1.2% | 0.01% | 0.0% |
| Q2 2019 | $3,786,000 | +23.1% | 220,397 | +15.4% | 0.01% | +16.7% |
| Q1 2019 | $3,076,000 | +7.6% | 191,052 | -2.2% | 0.01% | -14.3% |
| Q4 2018 | $2,859,000 | -17.6% | 195,436 | +2.3% | 0.01% | 0.0% |
| Q3 2018 | $3,470,000 | +7.7% | 190,953 | -0.0% | 0.01% | 0.0% |
| Q2 2018 | $3,222,000 | -9.5% | 190,964 | +5.1% | 0.01% | -12.5% |
| Q1 2018 | $3,561,000 | -6.6% | 181,752 | -3.4% | 0.01% | 0.0% |
| Q4 2017 | $3,811,000 | +14.9% | 188,124 | -1.5% | 0.01% | +14.3% |
| Q3 2017 | $3,317,000 | +33.8% | 190,935 | -1.3% | 0.01% | +40.0% |
| Q2 2017 | $2,480,000 | -10.9% | 193,466 | -9.9% | 0.01% | -16.7% |
| Q1 2017 | $2,783,000 | +25.3% | 214,738 | -4.5% | 0.01% | +20.0% |
| Q4 2016 | $2,221,000 | -20.3% | 224,838 | -2.6% | 0.01% | -16.7% |
| Q3 2016 | $2,787,000 | +41.3% | 230,738 | +0.9% | 0.01% | +50.0% |
| Q2 2016 | $1,973,000 | -7.5% | 228,638 | +1.4% | 0.00% | -20.0% |
| Q1 2016 | $2,134,000 | -37.3% | 225,378 | +14.7% | 0.01% | -37.5% |
| Q4 2015 | $3,406,000 | +31.1% | 196,510 | +1.6% | 0.01% | +14.3% |
| Q3 2015 | $2,598,000 | -40.6% | 193,414 | -0.2% | 0.01% | -36.4% |
| Q2 2015 | $4,374,000 | +61.8% | 193,714 | +2.3% | 0.01% | +83.3% |
| Q1 2015 | $2,704,000 | +46.0% | 189,348 | -1.4% | 0.01% | +50.0% |
| Q4 2014 | $1,852,000 | +6.5% | 191,948 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $1,739,000 | -6.8% | 191,132 | +1.3% | 0.00% | -20.0% |
| Q2 2014 | $1,865,000 | -16.2% | 188,748 | +7.7% | 0.01% | -16.7% |
| Q1 2014 | $2,226,000 | -7.6% | 175,248 | +9.0% | 0.01% | -14.3% |
| Q4 2013 | $2,410,000 | +36.5% | 160,748 | +0.6% | 0.01% | +40.0% |
| Q3 2013 | $1,765,000 | +43.6% | 159,848 | +3.3% | 0.01% | +25.0% |
| Q2 2013 | $1,229,000 | +36.9% | 154,805 | -0.6% | 0.00% | +33.3% |
| Q1 2013 | $898,000 | – | 155,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |